Century Therapeutics (IPSC) Competitor Comparison
We are evaluating the key criteria listed to compare Century Therapeutics (IPSC) against its competitors in the Biotechnology industry.
Market Capitalization
218 / 368Gross Profits
0 / 278Total Revenue
219 / 300EBITDA
221 / 337Free Cashflow
260 / 352Quick Ratio
106 / 357Earnings per Share
195 / 359Dividend yield
0 / 6Total Cash
174 / 358Performance 3 years
321 / 368Performance 5 years
300 / 368Performance 10 years
266 / 368Linearity 3 years
241 / 368Linearity 5 years
268 / 368Linearity 10 years
232 / 368Total Rank
81 / 368Dividend Rank
83 / 368Valuation Rank
62 / 368Piotroski Rank
61 / 368Muliplier Rank
309 / 368Total Cash - IPSC ranking 174 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.